title: Cancer germline gene activation: friend or foe?
authors.affiliation: North West Cancer Research Institute; Bangor University; Bangor, UK.
authors.forename: Ramsay J
authors.initials: RJ
authors.lastname: McFarlane
authors.affiliation: Institute for Knowledge Discovery; Graz University of Technology; Graz, Austria; Core Facility Bioinformatics; Austrian Centre of Industrial Biotechnology; Graz, Austria.
authors.forename: Julia
authors.initials: J
authors.lastname: Feichtinger
authors.affiliation: MRC Functional Genomics Unit; Department of Physiology, Anatomy and Genetics; University of Oxford; Oxford; UK.
authors.forename: Lee
authors.initials: L
authors.lastname: Larcombe
mesh_terms: D053687:Adult Stem Cells / Q000378:metabolism* / Q000473:pathology; D002454:Cell Differentiation; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D015972:Gene Expression Regulation, Neoplastic; D042822:Genomic Instability; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D014411:Neoplastic Stem Cells / Q000378:metabolism* / Q000473:pathology; D013094:Spermatozoa / Q000378:metabolism* / Q000473:pathology; D015533:Transcriptional Activation
keywords: cancer/testis antigen; drug resistance; germline; meiosis; oncogenesis
references.citation: Oncotarget. 2012 Aug;3(8):843-53
references.pmid: 22918178
references.citation: Science. 2010 Dec 24;330(6012):1824-7
references.pmid: 21205669
references.citation: Sci Transl Med. 2013 May 22;5(186):186ra66
references.pmid: 23698379
references.citation: Annu Rev Pharmacol Toxicol. 2014;54:251-72
references.pmid: 24160706
references.citation: Oncoscience. 2014 May 06;1(5):349-359
references.pmid: 25594029
references.citation: Nature. 2007 Apr 12;446(7137):815-9
references.pmid: 17429401
references.citation: Int J Cancer. 2014 May 15;134(10):2359-65
references.pmid: 24243547